Format

Send to:

Choose Destination
See comment in PubMed Commons below
Dermatol Ther. 2007 Jul-Aug;20(4):206-15.

Azathioprine: a guide for the management of dermatology patients.

Author information

  • 1University of Louisville, School of Medicine, School of Public Health and Information Sciences, Louisville, Kentucky, USA.

Abstract

Azathioprine, a prodrug of 6-mercaptopurine, was developed over four decades ago. Since its development, azathioprine has been shown to have antileukemic, anti-inflammatory, and immunosuppressive properties. Hence, the reason azathioprine is used in multiple medical specialties. In the dermatology field, it is used as an immunosuppressant and corticosteroid-sparing agent for the treatment of several cutaneous diseases. In this article, the present authors review the following aspects relating to azathioprine: history, pharmacokinetics, significance of thiopurine methyltransferase, side effects, contraindications, therapeutic uses, and recommended evaluation and monitoring for patients initiating azathioprine.

PMID:
17970886
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk